391 related articles for article (PubMed ID: 28032914)
1. Pleomorphic mantle cell lymphoma morphologically mimicking diffuse large B cell lymphoma: common cyclin D1 negativity and a simple immunohistochemical algorithm to avoid the diagnostic pitfall.
Chuang WY; Chang H; Chang GJ; Wang TH; Chang YS; Wang TH; Yeh CJ; Ueng SH; Chien HP; Chang CY; Wan YL; Hsueh C
Histopathology; 2017 May; 70(6):986-999. PubMed ID: 28032914
[TBL] [Abstract][Full Text] [Related]
2. Identification of CD5/Cyclin D1 Double-negative Pleomorphic Mantle Cell Lymphoma: A Clinicopathologic, Genetic, and Gene Expression Study.
Chuang WY; Chang ST; Yuan CT; Chang GJ; Chang H; Yeh CJ; Ueng SH; Kao HW; Wang TH; Wan YL; Shih LY; Chuang SS; Hsueh C
Am J Surg Pathol; 2020 Feb; 44(2):232-240. PubMed ID: 31688139
[TBL] [Abstract][Full Text] [Related]
3. SOX11 is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma.
Hsiao SC; Cortada IR; Colomo L; Ye H; Liu H; Kuo SY; Lin SH; Chang ST; Kuo TU; Campo E; Chuang SS
Histopathology; 2012 Oct; 61(4):685-93. PubMed ID: 22642745
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases.
Al-Kawaaz M; Mathew S; Liu Y; Gomez ML; Chaviano F; Knowles DM; Orazi A; Tam W
Am J Clin Pathol; 2015 Feb; 143(2):288-99. PubMed ID: 25596256
[TBL] [Abstract][Full Text] [Related]
5. Primary large B-cell lymphoma of the central nervous system with cyclin D1 expression and t(11;14) (IGH-CCND1): Diffuse large B-cell lymphoma with CCND1 rearrangement or mantle cell lymphoma?
Parrott AM; Haggiagi AM; Murty VV; Bhagat G; Alobeid B
Hematol Oncol; 2020 Dec; 38(5):817-822. PubMed ID: 32639587
[TBL] [Abstract][Full Text] [Related]
6. SOX11+ Large B-Cell Neoplasms: Cyclin D1-Negative Blastoid/Pleomorphic Mantle Cell Lymphoma or Large B-Cell Lymphoma?
Li S; Tang G; Jain P; Lin P; Xu J; Miranda RN; Cheng J; Yin CC; You MJ; Wang ML; Medeiros LJ
Mod Pathol; 2024 Feb; 37(2):100405. PubMed ID: 38104893
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.
Ok CY; Xu-Monette ZY; Tzankov A; O'Malley DP; Montes-Moreno S; Visco C; Møller MB; Dybkaer K; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Han van Krieken J; Ponzoni M; Farnen JP; Piris MA; Winter JN; Medeiros LJ; Young KH
Cancer; 2014 Jun; 120(12):1818-29. PubMed ID: 24648050
[TBL] [Abstract][Full Text] [Related]
8. CD5-negative blastoid variant mantle cell lymphoma: a diagnostic dilemma.
Yamamoto N; Maeshima AM; Taniguchi H; Makita S; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Izutsu K
Hum Pathol; 2021 May; 111():84-91. PubMed ID: 33727166
[TBL] [Abstract][Full Text] [Related]
9. Clinical, morphologic, phenotypic, and genetic evidence of cyclin D1-positive diffuse large B-cell lymphomas with CYCLIN D1 gene rearrangements.
Juskevicius D; Ruiz C; Dirnhofer S; Tzankov A
Am J Surg Pathol; 2014 May; 38(5):719-27. PubMed ID: 24722063
[TBL] [Abstract][Full Text] [Related]
10. Mantle cell lymphoma: improved diagnostics using a combined approach of immunohistochemistry and identification of t(11;14)(q13;q32) by polymerase chain reaction and fluorescence in situ hybridization.
Kodet R; Mrhalová M; Krsková L; Soukup J; Campr V; Neskudla T; Szépe P; Plank L
Virchows Arch; 2003 Jun; 442(6):538-47. PubMed ID: 12728315
[TBL] [Abstract][Full Text] [Related]
11. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
[TBL] [Abstract][Full Text] [Related]
12. CD5-positive, cyclinD1-negative mantle cell lymphoma with a translocation involving the CCND2 gene and the IGL locus.
Shiller SM; Zieske A; Holmes H; Feldman AL; Law ME; Saad R
Cancer Genet; 2011 Mar; 204(3):162-4. PubMed ID: 21504716
[TBL] [Abstract][Full Text] [Related]
13. [Importance of cyclin D1 (and CD5) detection in the diagnosis of malignant lymphomas other than mantle cell lymphoma].
Plank L
Cesk Patol; 2011 Jul; 47(3):96-100. PubMed ID: 21887925
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 expression and polysomy in lymphocyte-predominant cells of nodular lymphocyte-predominant Hodgkin lymphoma.
Cho BB; Kelting SM; Gru AA; LeGallo RD; Pramoonjago P; Goldin TA; Heitz CT; Aguilera NS
Ann Diagn Pathol; 2017 Feb; 26():10-15. PubMed ID: 28038705
[TBL] [Abstract][Full Text] [Related]
15. Determination of cyclin D1 and CD20 mRNA levels by real-time quantitative RT-PCR from archival tissue sections of mantle cell lymphoma and other non-Hodgkin's lymphomas.
Thomázy VA; Luthra R; Uthman MO; Davies PJ; Medeiros LJ
J Mol Diagn; 2002 Nov; 4(4):201-8. PubMed ID: 12411587
[TBL] [Abstract][Full Text] [Related]
16. Real-time quantitative RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohistochemistry.
Hui P; Howe JG; Crouch J; Nimmakayalu M; Qumsiyeh MB; Tallini G; Flynn SD; Smith BR
Leuk Lymphoma; 2003 Aug; 44(8):1385-94. PubMed ID: 12952233
[TBL] [Abstract][Full Text] [Related]
17. Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2.
Chuang SS; Huang WT; Hsieh PP; Tseng HH; Campo E; Colomer D; Ye H; Lu CL; Chang HM; Cho CY; Huang SH; Lu YC; Wu JD
Pathol Int; 2006 Aug; 56(8):440-8. PubMed ID: 16872438
[TBL] [Abstract][Full Text] [Related]
18. A cyclin D1-negative mantle cell lymphoma with an IGL-CCND2 translocation that relapsed with blastoid morphology and aggressive clinical behavior.
Kurita D; Takeuchi K; Kobayashi S; Hojo A; Uchino Y; Sakagami M; Ohtake S; Takahashi H; Miura K; Iriyama N; Sugitani M; Miyoshi H; Hatta Y; Ohshima K; Takei M
Virchows Arch; 2016 Oct; 469(4):471-6. PubMed ID: 27457074
[TBL] [Abstract][Full Text] [Related]
19. Morphologic diagnosis of leukaemic B-lymphoproliferative disorders and the role of cyclin D1 expression.
Oertel J; Kingreen D; Busemann C; Stein H; Dörken B
J Cancer Res Clin Oncol; 2002 Apr; 128(4):182-8. PubMed ID: 11935308
[TBL] [Abstract][Full Text] [Related]
20. CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma.
Salaverria I; Royo C; Carvajal-Cuenca A; Clot G; Navarro A; Valera A; Song JY; Woroniecka R; Rymkiewicz G; Klapper W; Hartmann EM; Sujobert P; Wlodarska I; Ferry JA; Gaulard P; Ott G; Rosenwald A; Lopez-Guillermo A; Quintanilla-Martinez L; Harris NL; Jaffe ES; Siebert R; Campo E; Beà S
Blood; 2013 Feb; 121(8):1394-402. PubMed ID: 23255553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
